Vigil Health Solutions Announces Private Placement to Raise Up to $520,000

Vigil Health Solutions Inc. (TSX VENTURE:VGL) ("Vigil") announced today a
proposed non-brokered private placement of up to 8,000,000 units of Vigil at a
price of $0.065 per unit, for proceeds of up to $520,000. Each unit will consist
of one common share and a half warrant. Each whole warrant entitles the holder
to purchase an additional common share at a price of $0.10 per share for a
period of two years from closing of the private placement.


The private placement is subject to regulatory approval including the approval
of the TSX Venture Exchange.


The net proceeds of the private placement are planned to be used to fund further
development of Vigil's products, for working capital and for general corporate
practices.


Forward Looking Statements

Certain statements in this press release contain forward-looking information
within the meaning of applicable securities laws in Canada ("forward-looking
information"). The words "anticipates", "believes", "budgets", "could",
"estimates", "expects", "forecasts", "intends", "may", "might", "plans",
"projects", "schedule", "should", "will", "would" and similar expressions are
often intended to identify forward-looking information, although not all
forward-looking information contains these identifying words.


The forward-looking information in this press release includes, but is not
limited to: Vigil's intention to conduct a private placement and the planned use
of proceeds from the private placement.


The forecasts and projections that make up the forward-looking information are
based on assumptions which include, but are not limited to: Vigil is able to
develop its sales force and generate revenue in the current economic climate,
Vigil is able to manage the length of the sales cycle, Vigil is able to manage
its growth, Vigil is able to recruit and retain staff, fluctuations in demand
for current and future products is limited, Vigil is able to develop,
manufacture, supply and market existing and new products that meet the needs of
customers, volatility in the exchange rate is limited, Vigil is able to secure
financing, Vigil is able to secure product liability insurance, the continuous
commitment of Vigil's customers, competition does not increase, limited changes
in regulation and no changes to third party suppliers on which Vigil relies.


The forward-looking information is subject to risks, uncertainties and other
factors that could cause actual results to differ materially from historical
results or results anticipated by the forward-looking information. The factors
which could cause results to differ from current expectations include, but are
not limited to: Vigil's ability to develop its sales force and generate revenue
in the current economic climate, the length of the sales cycle, management of
the Vigil's growth, ability to recruit and retain staff, fluctuations in demand
for current and future products, Vigil's ability to develop, manufacture, supply
and market existing and new products that meet the needs of customers,
volatility in the exchange rate, ability to secure financing, ability to secure
product liability insurance, the continuous commitment of Vigil's customers,
increased competition, changes in regulation and reliance on third party
suppliers; and, other risks described in Vigil's Management Discussion &
Analysis and other continuous disclosure documents.


All forward-looking information in this press release is qualified in its
entirety by this cautionary statement and, except as may be required by law,
Vigil undertakes no obligation to revise or update any forward-looking
information as a result of new information, future events or otherwise after the
date hereof.

Vigil Health Solutions (TSXV:VGL)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024